Det verkar som ett fel inträffade när du försökte ladda denna sida.
Vårt team har meddelats men vänligen kontakta oss via widget för e-postsupport om problemet kvarstår.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 0,8x - 0,9x | 0,9x |
| Selected Fwd Revenue Multiple | 0,8x - 0,9x | 0,8x |
| Fair Value | ₩26.951 - ₩32.811 | ₩29.881 |
| Upside | -37,6% - -24,0% | -30,8% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| JW Pharmaceutical Corporation | A001060 | KOSE:A001060 |
| Dong-A ST Co., Ltd. | A170900 | KOSE:A170900 |
| Chong Kun Dang Holdings Corp. | A001630 | KOSE:A001630 |
| JW Holdings Corporation | A096760 | KOSE:A096760 |
| Jeil Pharmaceutical Co.,Ltd | A271980 | KOSE:A271980 |
| Huons Global Co., Ltd. | A084110 | KOSDAQ:A084110 |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| A001060 | A170900 | A001630 | A096760 | A271980 | A084110 | |||
| KOSE:A001060 | KOSE:A170900 | KOSE:A001630 | KOSE:A096760 | KOSE:A271980 | KOSDAQ:A084110 | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | 7.1% | 3.2% | 5.9% | 4.0% | 1.0% | 14.9% | ||
| 3Y CAGR | 5.8% | 4.2% | 1.1% | 4.0% | 0.2% | 13.2% | ||
| Latest Twelve Months | -3.9% | 5.1% | 8.9% | -4.3% | -3.0% | 10.9% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 6.1% | 3.0% | 3.8% | 10.1% | -0.7% | 14.7% | ||
| Prior Fiscal Year | 12.9% | 1.7% | 1.9% | 15.5% | 1.2% | 13.1% | ||
| Latest Fiscal Year | 11.5% | -3.6% | 3.7% | 16.5% | -2.6% | 15.3% | ||
| Latest Twelve Months | 11.5% | -3.6% | 3.7% | 16.5% | -2.6% | 11.6% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 0.72x | 0.85x | 0.92x | 0.92x | 0.31x | 1.08x | ||
| EV / LTM EBIT | 6.2x | -27.1x | 24.9x | 5.6x | -11.6x | 9.3x | ||
| Price / LTM Sales | 0.72x | 0.60x | 0.62x | 0.24x | 0.25x | 0.65x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 0.31x | 0.85x | 0.92x | |||||
| Historical EV / LTM Revenue | 0.59x | 1.03x | 1.28x | |||||
| Selected EV / LTM Revenue | 0.84x | 0.89x | 0.93x | |||||
| (x) LTM Revenue | 811,008 | 811,008 | 811,008 | |||||
| (=) Implied Enterprise Value | 683,859 | 719,851 | 755,844 | |||||
| (-) Non-shareholder Claims * | (349,773) | (349,773) | (349,773) | |||||
| (=) Equity Value | 334,086 | 370,078 | 406,071 | |||||
| (/) Shares Outstanding | 12.2 | 12.2 | 12.2 | |||||
| Implied Value Range | 27,429.00 | 30,384.05 | 33,339.10 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 27,429.00 | 30,384.05 | 33,339.10 | 43,200.00 | ||||
| Upside / (Downside) | -36.5% | -29.7% | -22.8% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A001060 | A170900 | A001630 | A096760 | A271980 | A084110 | |
| Enterprise Value | 517,451 | 570,690 | 883,677 | 818,630 | 216,068 | 875,950 | |
| (+) Cash & Short Term Investments | 32,551 | 301,078 | 61,116 | 74,179 | 57,455 | 267,789 | |
| (+) Investments & Other | 63,801 | 82,549 | 393,489 | 50,285 | 8,342 | 93,231 | |
| (-) Debt | (91,726) | (495,663) | (479,654) | (435,872) | (75,695) | (272,040) | |
| (-) Other Liabilities | (0) | (38,522) | (262,275) | (291,854) | (31,167) | (432,107) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | (6,647) | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 522,077 | 420,133 | 596,353 | 215,368 | 175,004 | 526,177 | |
| (/) Shares Outstanding | 23.3 | 9.2 | 13.6 | 70.7 | 14.6 | 12.2 | |
| Implied Stock Price | 22,400.00 | 45,850.00 | 44,000.00 | 3,045.00 | 12,010.00 | 43,200.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 22,400.00 | 45,850.00 | 44,000.00 | 3,045.00 | 12,010.00 | 43,200.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |